Michael Rogers provisionally suspended by the UCI after clenbuterol found in urine sample

Expert road bike reviews and the latest road bike news, features and advice. Find rides & events, training articles and participate in our forums

Share

Racing

Michael Rogers provisionally suspended by UCI after clenbuterol found in urine sample

Australian awaits B sample result after positive test following Japan Cup victory

Michael Rogers (Tinkoff-Saxo) has been provisionally suspended by the UCI after a urine sample taken at the Japan Cup revealed traces of clenbuterol.

The Australian rider, 33, joined the Danish team for the 2013 season and won the 1.HC-ranked event in Japan on October 20.

However, a UCI statement released today revealed a urine sample taken at the race had uncovered ‘an adverse analytical finding of clenbuterol’.

Michael Rogers leads the bunch up the Muro di Sormano in the 2013 Giro di Lombardio. pic: ©Sirotti

The statement read: “The UCI advised Australian rider Michael Rogers that he is provisionally suspended.

“The decision to provisionally suspend this rider was made in response to a report from the WADA-accredited laboratory in Tokyo indicating an adverse analytical finding of clenbuterol in a urine sample collected from him in a test during the Japan Cup Cycle Road Race on October 20, 2013.

“The provisional suspension of Mr. Michael Rogers remains in force until a hearing panel convened by his national federation determines whether he has committed an anti-doping rule violation under Article 21 of the UCI Anti-Doping Rules.

“Mr. Rogers has the right to request and attend the analysis of his B sample.”

Rogers was a member of the Team Sky squad which helped Sir Bradley Wiggins to win the 2012 Tour de France.

He joined Team Saxo-Tinkoff after two years with the British team, finishing 16th overall at this year’s Tour, where he rode in support of Alberto Contador.

Prior to joining Sky in 2011, Rogers was a three-time world time trial champion, having won successive titles between 2003 and 2005.

Share

Newsletter Terms & Conditions

Please enter your email so we can keep you updated with news, features and the latest offers. If you are not interested you can unsubscribe at any time. We will never sell your data and you'll only get messages from us and our partners whose products and services we think you'll enjoy.

Read our full Privacy Policy as well as Terms & Conditions.

production